Market Tracker

05/26 5:16pm ET

Immunomedics Inc (NASDAQ:IMMU)

4.33
Delayed Data
As of 4:00pm ET
 -0.21 / -4.63%
Today’s Change
1.50
Today|||52-Week Range
5.05
+41.04%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close4.54
Today’s open4.57
Day’s range4.23 - 4.61
Volume2,291,759
Average volume (3 months)1,091,822
Market cap$430.4M
Dividend yield--
Data as of 4:00pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)-21.43%
Earnings growth (this year)-8.82%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-37.48%
P/E ratioNM
Price/Sales67.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARAYAccuray Inc-0.01-0.18%
HTWRHeartWare Internatio...-0.85-2.87%
ENTLEntellus Medical Inc-0.03-0.17%
NVDQNovadaq Technologies...-0.07-0.72%
Data as of 4:00pm ET, 05/26/2016

Financials

Next reporting dateAugust 18, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$5.7M
Annual profit (last year)-$48.0M
Net profit margin-849.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts